Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/2675
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIbáñez-Costa, Alejandro-
dc.contributor.authorLópez-Sánchez, Laura M-
dc.contributor.authorGahete, Manuel D-
dc.contributor.authorRivero-Cortés, Esther-
dc.contributor.authorVázquez-Borrego, Mari C-
dc.contributor.authorGálvez, María A-
dc.contributor.authorde la Riva, Andrés-
dc.contributor.authorVenegas-Moreno, Eva-
dc.contributor.authorJiménez-Reina, Luis-
dc.contributor.authorMoreno-Carazo, Alberto-
dc.contributor.authorTinahones, Francisco J-
dc.contributor.authorMaraver-Selfa, Silvia-
dc.contributor.authorJapón, Miguel A-
dc.contributor.authorGarcía-Arnés, Juan A-
dc.contributor.authorSoto-Moreno, Alfonso-
dc.contributor.authorWebb, Susan M-
dc.contributor.authorKineman, Rhonda D-
dc.contributor.authorCuller, Michael D-
dc.contributor.authorCastaño, Justo P-
dc.contributor.authorLuque, Raúl M-
dc.date.accessioned2017-05-26T11:52:48Z-
dc.date.available2017-05-26T11:52:48Z-
dc.date.issued2017-02-09-
dc.identifier.citationIbáñez-Costa A, López-Sánchez LM, Gahete MD, Rivero-Cortés E, Vázquez-Borrego MC, Gálvez MA, et al. BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas. Sci Rep. 2017; Feb 9;7:42002es_ES
dc.identifier.issn2045-2322 (Online)es_ES
dc.identifier.otherPMC5299479es_ES
dc.identifier.urihttp://hdl.handle.net/10668/2675-
dc.description.abstractChimeric somatostatin/dopamine compounds such as BIM-23A760, an sst2/sst5/D2 receptors-agonist, have emerged as promising new approaches to treat pituitary adenomas. However, information on direct in vitro effects of BIM-23A760 in normal and tumoral pituitaries remains incomplete. The objective of this study was to analyze BIM-23A760 effects on functional parameters (Ca(2+) signaling, hormone expression/secretion, cell viability and apoptosis) in pituitary adenomas (n = 74), and to compare with the responses of normal primate and human pituitaries (n = 3-5). Primate and human normal pituitaries exhibited similar sst2/sst5/D2 expression patterns, wherein BIM-23A760 inhibited the expression/secretion of several pituitary hormones (specially GH/PRL), which was accompanied by increased sst2/sst5/D2 expression in primates and decreased Ca(2+) concentration in human cells. In tumoral pituitaries, BIM-23A760 also inhibited Ca(2+) concentration, hormone secretion/expression and proliferation. However, BIM-23A760 elicited stimulatory effects in a subset of GHomas, ACTHomas and NFPAs in terms of Ca(2+) signaling and/or hormone secretion, which was associated with the relative somatostatin/dopamine-receptors levels, especially sst5 and sst5TMD4. The chimeric sst2/sst5/D2 compound BIM-23A760 affects multiple, clinically relevant parameters on pituitary adenomas and may represent a valuable therapeutic tool. The relative ssts/D2 expression profile, particularly sst5 and/or sst5TMD4 levels, might represent useful molecular markers to predict the ultimate response of pituitary adenomas to BIM-23A760.es_ES
dc.description.sponsorshipThis work has been funded by the following grants: Junta de Andalucía (BIO-0139, CTS-1406, PI-639-2012); Ministerio de Economía y Competitividad, Gobierno de España (BFU2013-43282) ; Proyectos de Investigación en Salud FIS, funded by Instituto de Salud Carlos III (PI13-00651, co-funded by ERDF/ESF, “Investing in your future”); Instituto de Salud Carlos III, Ministerio de Sanidad, Servicios Sociales e Igualdad ‘CIBERobn’; and Ayuda Merck Serono 2013 (to RML and JPC). Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development Merit Award and the National Institutes of Health: R21AG031465 and R01DK088133 (to RDK).es_ES
dc.language.isoenes_ES
dc.publisherNature Publishing Groupes_ES
dc.relation.ispartofScientific Reportses_ES
dc.subjectAdenoma hipofisario secretor de ACTHes_ES
dc.subjectAdenomaes_ES
dc.subjectApoptosises_ES
dc.subjectSupervivencia celulares_ES
dc.subjectDopaminaes_ES
dc.subjectHumanoses_ES
dc.subjectHormonas hipofisariases_ES
dc.subjectNeoplasias hipofisariases_ES
dc.subjectPrimateses_ES
dc.subjectReceptores dopaminérgicoses_ES
dc.subjectReceptores de somatostatinaes_ES
dc.subjectSomatostatinaes_ES
dc.subject.meshMedical Subject Headings::Diseases::Endocrine System Diseases::Endocrine Gland Neoplasms::Pituitary Neoplasms::ACTH-Secreting Pituitary Adenomaes_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Death::Apoptosises_ES
dc.subject.meshMedical Subject Headings::Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Adenomaes_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Cell Physiological Phenomena::Cell Physiological Processes::Cell Survivales_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amines::Catecholamines::Dopaminees_ES
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Peptide Hormones::Pituitary Hormoneses_ES
dc.subject.meshMedical Subject Headings::Diseases::Endocrine System Diseases::Pituitary Diseases::Pituitary Neoplasmses_ES
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primateses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, Neurotransmitter::Receptors, Biogenic Amine::Receptors, Catecholamine::Receptors, Dopaminees_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, Neurotransmitter::Receptors, Neuropeptide::Receptors, Somatostatines_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Peptide Hormones::Hypothalamic Hormones::Pituitary Hormone Release Inhibiting Hormones::Somatostatines_ES
dc.titleBIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomases_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.description.versionYeses_ES
dc.identifier.pmid28181484es_ES
dc.rights.accessRightsAcceso abiertoes_ES
dc.identifier.doi10.1038/srep42002es_ES
dc.type.versioninfo:eu-repo/semantics/publishedes_ES
dc.relation.publisherversionhttps://www.nature.com/articles/srep42002es_ES
dc.contributor.authoraffiliation[Ibáñez-Costa,A; López-Sánchez,LM; Gahete,MD; Rivero-Cortés,E; Vázquez-Borrego,MC; Gálvez,MA; de la Riva,A; Castaño,JP; Luque,RM] Maimonides Institute of Biomedical Research of Cordoba (IMIBIC); Cordoba, Spain. [Ibáñez-Cortes,A; Gahete,MD; Rivero-Cortés,E; Vázquez-Borrego,MC; Castaño,JP; Luque, RM] Department of Cell Biology, Physiology and Immunology, University of Cordoba; Cordoba, Spain. [Ibáñez-Costa,A; López-Sánchez,LM; Gahete,MD; Rivero-Cortés,E; Vázquez-Borrego,MC; Gálvez,MA; de la Riva,A; Castaño,JP; Luque,RM] Hospital Universitario Reina Sofía (HURS); Cordoba, Spain. [Ibáñez-Costa,A; Gahete,MD; Rivero-Cortés,E; Vázquez-Borrego,MC; Castaño,JP; Luque,RM] CIBER de la Fisiopatología de la Obesidad y Nutrición (CIBERobn); Cordoba, Spain. Campus de Excelencia Internacional Agroalimentario (ceiA3); Cordoba, Spain. [Gálvez,MA] Service of Endocrinology and Nutrition, IMIBIC, HURS, Cordoba, Spain. [de la Riva,A] Service of Neurosurgery, HURS, Cordoba, Spain. [Venegas-Moreno,E; Soto-Moreno,A] Metabolism and Nutrition Unit, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS), Seville, Spain. [Jiménez-Reina,L] Department of Morphological Sciences, University of Cordoba, Cordoba, Spain. [Moreno-Carazo,A] Endocrinology and Nutrition Unit, Complejo Hospitalario de Jaén, Jaén, Spain. [Maraver-Selfa,S] Service of Endocrinology and Nutrition, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain. [Japón,MA] Department of Pathology, Hospital Universitario Virgen del Rocío, Seville, Spain. [García-Arnés,JA] Department of Endocrinology and Nutrition, Carlos Haya Hospital, Málaga, Spain. [Webb-SM] Department of Endocrinology, Hospital Sant Pau, Centre for Biomedical Research on Rare Diseases (Centro de Investigación Biomédica en Red de Enfermedades Raras Unit 747) Autonomous University of Barcelona; Barcelona Spain. [Kineman,RD] Department of Medicine, University of Illinois at Chicago, Jesse Brown Veterans Affairs Medical Center, Research and Development Division, Chicago, Illinois, USA. [Culler,MD] IPSEN Bioscience, Cambridge, Massachusetts, USA.es_ES
Appears in Collections:01- Artículos - Hospital Virgen de la Victoria
01- Artículos - Complejo Hospitalario de Jaén
01- Artículos - IBIS. Instituto de Biomedicina de Sevilla
01- Artículos - Hospital Virgen del Rocío
01- Artículos - Hospital Reina Sofía
01- Artículos - IMIBIC. Instituto Maimónides de Investigación Biomédica de Córdoba
01- Artículos - Hospital Regional de Málaga

Files in This Item:
File Description SizeFormat 
IbañezCostaI_BIM23A760Influences.pdfArtículo publicado1,33 MBAdobe PDFView/Open
IbañezCostaI_BIM23A760Influences_MatSuppl.pdfTable1AndFigures135,7 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons